Longevity Gene Regulatory Network (GRN) Predictive Modeling & Optimization Services
Creative Biolabs' longevity GRN predictive modeling & optimization services deliver a high-resolution, causal map of the aging process. We provide master regulator gene prioritization and dynamic simulation using network control theory. Clients gain a competitive advantage by receiving quantifiable Controllability Scores for their targets, enabling rapid de-risking of lead assets and precise polypharmacology combination strategies. This results in significantly accelerated discovery timelines and a clear, in silico validated roadmap to reverse the aged cellular state.
Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Introduction: The Systems Biology of Longevity
Aging is understood as a system-wide collapse of the Gene Regulatory Network (GRN) stability. Research demonstrates that aging is driven by the progressive dysregulation of thousands of interconnected genes, concentrating vulnerability in critical "network hubs." Our service leverages network control theory and dynamic simulation, modeled after the Waddington landscape, to identify the most efficient points of intervention. This approach is validated by recent literature showing that therapeutic targets must be selected for their causal power over the entire network, not just localized effects.
For an in-depth analysis of how our services can be tailored to your specific project needs, request a consultation.
Fig.1 The GRN construction module and the driver regulator identification module. 1
What We Can Offer
Customized Network Modeling
We offer flexible project execution in batch, fed-batch, or continuous modeling mode - tailoring the GRN complexity and perturbation analysis to your specific therapeutic goal, whether it's disease reversal, tissue-specific regeneration, or generalized healthspan extension.
Master Regulator Guarantee & Causal Clarity
We employ rigorous, quality-assured procedures to identify the true causal Master Regulator Genes (MRGs), ensuring your targets represent the most effective points of intervention—the critical "network hubs."
Large-Scale Data Integration Capacity
Our platform is engineered to handle massive, multi-modal datasets, including tens of thousands of single-cell omics profiles, providing the statistical power and resolution necessary for large-scale, industrial-grade analysis.
Quantifiable Therapeutic Efficiency
Utilizing Quality-by-Design (QbD) principles for computational biology, we generate a Controllability Score for every target. This metric provides a quantified, high-standard quality control tool to measure therapeutic efficiency and de-risk assets in silico.
Optimized Poly-Pharmacology Strategies
Our proprietary Optimization Algorithm systematically searches the combinatorial space, allowing us to optimize culture conditions (in silico) to maximize yield—pinpointing synergistic compound combinations that achieve the highest efficacy at the minimal required dose.
Longevity GRN Predictive Modeling & Optimization Service at Creative Biolabs
Mathematical Modeling based Longevity GRN Behavior Simulation & Prediction Service
This service maps the current biological system, constructing a dynamic GRN model using advanced mathematical frameworks like GNNs. It predicts network evolution under conditions, providing a critical "future state" analysis of potential disease trajectories and vulnerable nodes.
Learn More →
Longevity GRN Model Optimization Services
Building on simulation, this service applies network control theory to identify the minimum necessary external perturbations (targets/compounds) needed to return the aged system to a healthy Waddington landscape state. It generates optimal combination strategies using Controllability Scores.
Learn More →
Highlights
Rigorous Methodology
Creative Biolabs utilizes a rigorous scientific methodology with computational models directly applicable to therapeutic outcomes. This ensures high confidence in your investment and provides a data-backed approach to significantly cutting overall drug development timelines.
Systems-Level Control
We use a robust, systems-level approach validated by leading literature, focusing on the vulnerability of specific "network hubs" responsible for aging. This strategic targeting increases success rates by focusing only on the true causal drivers of dysregulation.
Accelerated Screening
Our computational analysis significantly boosts your drug lead compound screening efficiency. Clients consistently report a substantial increase in identifying viable assets, allowing for faster validation and reducing wasted resources on empirically testing low-potential candidates.
Resource Optimization
By accurately predicting synergistic combinations in silico, our service achieves notable resource optimization. Clients typically realize a significant reduction in time and costs associated with extensive, iterative empirical combination screening and costly validation assays.
To fully understand the Creative Biolabs' advantage, we invite you to get a quote today.
Customer Reviews
-
De-Risking Success
Using Creative Biolabs' GRN modeling in our research has significantly improved our ability to de-risk assets. The controllability scores provided a quantifiable confidence metric, allowing us to pivot away from a high-toxicity target early in development. - J. L***is
-
Causal Clarity
The causal inference engine was a game-changer. It cleanly separated true master regulator genes from co-expressed bystanders in our single-cell data, saving us months of costly validation on irrelevant targets. - Dr. A. P***ss.
FAQs
Q: Is your GRN modeling limited to specific disease areas, or can it be applied across different longevity targets?
A: Our platform is built on universal principles of network control and is highly adaptable. While we specialize in aging and age-related diseases, our framework integrates any single-cell or bulk multi-omics data, allowing us to model regulatory changes across various tissues, cell types, and specific phenotypes relevant to your therapeutic focus.
Q: What is the benefit of the controllability score, and how does it help de-risk a project?
A: The controllability score quantifies the calculated efficiency and power of an intervention to steer the network to the desired youthful state. A higher score means a more robust and predictable therapeutic effect, allowing you to prioritize targets with the greatest likelihood of systemic success and fewer compensating mechanisms.
Related Services
Multi-omic Analyses
For clients managing high-dimensional, heterogeneous datasets. We provide expert data standardization, rigorous quality control, and harmonization necessary to ensure optimal, unified input for robust GRN model construction.
Learn More →
Gene Expression Profiling
We offer comprehensive gene expression services, including advanced RNA-seq and digital PCR analysis, to identify key differentially expressed genes and pathways that define the aged or diseased state, providing the foundational input for GRN assembly.
Learn More →
How We Can Help
Creative Biolabs' longevity GRN predictive modeling & optimization services deliver unparalleled precision by mastering the aging network at the systems level. We transform complexity into certainty, providing you with high-leverage targets, validated combinations, and a powerful computational edge in the race for healthspan extension. Contact our team today for a detailed conversation about your project scope and objectives.
Reference
-
Wang, Peizhuo et al. "Deciphering driver regulators of cell fate decisions from single-cell transcriptomics data with CEFCON." Nature communications vol. 14,1 8459. 20 Dec. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41467-023-44103-3
For Research Use Only | Not For Clinical Use
